BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2015 | $250,000 | Replaced |
| 4th Quarter - Amendment | Sep 21, 2015 | $160,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
| ELIZABETH WOODY | — |
Medicare/Medicaid MMM
Issues related to device payment
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANNY LY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.